© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, EyePoint Pharmaceuticals, Inc. (EYPT) shows an Average True Range (ATR) of 1.03 and an Enterprise Value of 544.92M. Its average trading volume over the past 3 months is 1.32M, indicating liquidity. These fundamental metrics provide insight into EYPT's underlying financial health and market activity.
EyePoint Pharmaceuticals, Inc. (EYPT) technical indicators as of December 23, 2025: the SMA 20 is 16.82%, SMA 50 at 36.75%, and SMA 200 at 82.58%. The RSI 14 value is 71.95, suggesting its current momentum. These technical analysis signals help assess EYPT's price trends and potential future movements.
EyePoint Pharmaceuticals, Inc. (EYPT) stock performance overview as of December 23, 2025: The 52-week high is $19.11 (currently -1.36% below), and the 52-week low is $3.91 (currently 382.1% above). Over the past year, EYPT's performance is 147.7%, compared to the S&P 500's 10.56% change.
According to market data, EyePoint Pharmaceuticals, Inc. (EYPT) stock's recent performance metrics show that over the last month, EYPT is 32%, with a Year-to-Date (YTD) performance of 153.02%. Over the past year, the stock has seen a 147.7% change. These figures summarize EYPT's price movements across various periods, reflecting its historical returns.
According to current financial data, EYPT stock's P/E (TTM) ratio is -6.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for EYPT, including P/S (29.44), P/B (6.37), and P/FCF (-5.84), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.